Millennium Management
FTH

Millennium Management’s Faeth Therapeutics FTH Stock Holding History

Millennium Management’s Portfolio FTH Stock Details FTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.62M Buy
+146,565
New +$2.93M ﹤0.01% 3036
2024
Q2 		– Sell
-1,629
Closed -$34.2K – 6487
2024
Q1 		$34.2K Sell
1,629
-286
-15% -$4.93K ﹤0.01% 5745
2023
Q4 		$26.5K Sell
1,915
-950
-33% -$13K ﹤0.01% 5591
2023
Q3 		$43K Buy
2,865
+154
+6% +$3.31K ﹤0.01% 5516
2023
Q2 		$61.8K Sell
2,711
-799
-23% -$23.4K ﹤0.01% 5434
2023
Q1 		$105K Buy
3,510
+148
+4% +$4.38K ﹤0.01% 5409
2022
Q4 		$100K Sell
3,362
-592
-15% -$17.4K ﹤0.01% 5583
2022
Q3 		$123K Sell
3,954
-2,731
-41% -$107K ﹤0.01% 5894
2022
Q2 		$304K Buy
6,685
+4,198
+169% +$157K ﹤0.01% 5346
2022
Q1 		$115K Sell
2,487
-1,878
-43% -$149K ﹤0.01% 6086
2021
Q4 		$506K Sell
4,365
-8,568
-66% -$1.28M ﹤0.01% 5033
2021
Q3 		$2.72M Buy
+12,933
New +$2.35M ﹤0.01% 3562

Other funds holding FTH

VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
SC
Stempoint Capital New York $522M AUM 281.95% 1-Year Est. Return
CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $437M AUM
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

Millennium Management's FTH Position: Q1 2026 in Review

Millennium Management opened a new position in Faeth Therapeutics (FTH) in Q1 2026: 146,565 shares worth $4.62M. The stake represents ﹤0.01% of the portfolio and ranks #3036 among its holdings. This is a return to the name: Millennium Management previously reported a position in FTH as recently as Q1 2024.

Millennium Management first reported a position in FTH in Q3 2021 and has held it in 12 quarters since. 30 funds tracked by Wall St. Rank hold FTH as of Q1 2026.

  • Millennium Management held 146,565 shares of Faeth Therapeutics worth $4.62M as of Q1 2026.
  • Faeth Therapeutics was a new Millennium Management position in Q1 2026.
  • Faeth Therapeutics made up ﹤0.01% of Millennium Management's portfolio in Q1 2026, its #3036 holding.
  • Millennium Management first reported a position in Faeth Therapeutics in Q3 2021 and has held it in 12 quarters since.
  • 30 funds tracked by Wall St. Rank held Faeth Therapeutics as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.